Invitae Corporation

Industry

  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing

Other Names/Subsidiaries

  • CombiMatrix Corporation
  • Clear Genetics
  • Diploid
  • Jungla
  • CombiMatrix
See more in Biomedtracker

Latest on Invitae Corporation

Medtech Insight

Invitae Claws At $50m, Selling Reproductive Health Assets

 
• By Barnaby Pickering

After posting consistently poor financial results, genetic-test developer Invitae has implemented its most drastic cost-saving measure to date, selling off its reproductive health business to Natera

Medtech Insight

IVD DNA Test For Cancer Receives New Regulatory Classification

 
• By Hannah Daniel

Invitae ’s Common Hereditary Cancers panel is a first of its kind for the diagnostics industry. On 29 September, the diagnostic received de novo authorization with special controls from the US Food

Scrip

Pharming Leniolisib Launch Will Require Identifying Patients With Ultra Rare APDS

 
• By Alaric DeArment

Pharming Group N.V. is on the cusp of scoring its second product approval, with the US Food and Drug Administration action date for leniolisib in activated phosophoinositide 3-kinase delta (PI3K-delt

Medtech Insight

Invitae Acquires Genosity In $200M Deal, Raises $1.15Bn From Softbank Group

 
• By Marion Webb

Invitae Corporation drove home a double decker this week with the announcement of a $200m buyout for the lab sequencing and software developer Genosity and a $1.15bn investment from a unit of Softban